Notice2022-13123
CDC Town Hall Meeting on Laboratory Biosafety-Use of Laboratory Instruments
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 17, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces a meeting regarding biosafety and laboratory instrumentation.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 117 (Friday, June 17, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 117 (Friday, June 17, 2022)]
[Notices]
[Page 36507]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-13123]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC Town Hall Meeting on Laboratory Biosafety--Use of Laboratory
Instruments
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces a
meeting regarding biosafety and laboratory instrumentation.
DATES: The meeting will be held on Friday, June 24, 2022, from 10 a.m.
to 3:30 p.m., EDT.
ADDRESSES: This meeting is open to the public through a virtual format,
limited only by the webcast lines available. Registration is not
required. Visit the CDC Safe Labs website for the meeting webcast at
<a href="https://www.cdc.gov/safelabs/biosafety-townhall.html">https://www.cdc.gov/safelabs/biosafety-townhall.html</a>.
FOR FURTHER INFORMATION CONTACT: Nancy E. Cornish M.D., Center for
Surveillance, Epidemiology and Laboratory Services, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta,
Georgia 30329-4018; Phone: (404)498-2720; Email: <a href="/cdn-cgi/l/email-protection#35515946575c5a46545350414c755651561b525a43"><span class="__cf_email__" data-cfemail="44202837262d2b37252221303d042720276a232b32">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The purpose of this meeting is to provide an overview and
discussion on laboratory biosafety when using laboratory instruments to
test human and biologic specimens. Meeting topics are listed in the
``Matters to be Considered'' section of this notice.
Matters to be Considered: The agenda will include presentations and
discussions on four topic areas: (1) instrument design and
incorporating biosafety; (2) perceived risks to laboratory personnel
and impact on testing; (3) independent assessment of risks and
instrument design; and (4) a discussion of potential areas of
collaboration to address issues discussed during the meeting. There
will be prepared presentations, discussions among presenters and
panelists, and a period for questions and public comments. Agenda items
are subject to change as priorities dictate.
Background: CDC's Division of Laboratory Systems is hosting the
town hall meeting in collaboration with clinical and public health
laboratory partners, and instrument manufacturers to address clinical
laboratory biosafety. The recent publication Clinical Laboratory
Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a
Safer Future (Cornish NE. et. al. Clinical Laboratory Biosafety Gaps:
Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.
Clin Microbiol Rev. July 2021, Vol. 34/3 e00126-18) discussed critical
gaps in clinical laboratory biosafety, including issues related to the
use and disinfection of laboratory instruments. The discussion and
feedback generated during the meeting will assist in evaluating current
biosafety guidance and identify opportunities for improvement in
clinical laboratory biosafety and use of laboratory instrumentation.
This meeting is a listening session. Participants may provide
individual advice or perspectives. CDC is not seeking consensus advice
or recommendations from participants.
Dated: June 14, 2022.
Angela K. Oliver,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2022-13123 Filed 6-16-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 17, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.